ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Scott T. Tagawa discussing ProstACT Global, a phase 3 study of 177 Lu-rosptamab + standard of care ...

Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking ...

New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide ...

Boulder, Montana, kept my dad alive. So did the government. My father never quite understood how I could live in New York City. He preferred Montana, open rather than dense, prairie rather than ...

ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Geoffrey Johnson discussing SECuRE, a dose escalation/expansion study to assess the anti-tumor ...